Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia

J Adv Pract Oncol. 2015 Jul-Aug;6(4):370-4. doi: 10.6004/jadpro.2015.6.4.7. Epub 2015 Jul 1.
No abstract available

Publication types

  • Review